The Valdecilla Institute for Health Research (IDIVAL) has recognized the work of seven young researchers in the latest edition of the NEXT-Val program (NEXT generation VALdecilla), an initiative that promotes translational research within Cantabria’s biomedical environment. Among the awardees is Daniel Álvarez, a postdoctoral researcher at IDIVAL, whose project addresses one of the body’s most […]
A team of rheumatology specialists from the Marqués de Valdecilla University Hospital (HUMV) and the Marqués de Valdecilla Health Research Institute (IDIVAL) has participated in a national multicenter study demonstrating the efficacy of baricitinib, a Janus kinase inhibitor, in patients with rheumatoid arthritis and associated pulmonary fibrosis. The study, published in the scientific journal Rheumatology […]
Her project seeks to anticipate complications and improve the efficacy and safety of these therapies in hematology patients Within the framework of the Valdecilla Health Research Institute (IDIVAL), Dr. Miriam Sánchez Escamilla has been recognized as an emerging researcher under the NEXT-Val program (NEXT generation VALdecilla), an initiative that promotes translational research in Cantabria. The […]
NEXT-Val Drives Research into New Predictive Models to Improve Prognosis in Severe Stroke Cases The Valdecilla Health Research Institute (IDIVAL) has awarded seven young researchers through the NEXT-Val program (NEXT generation VALdecilla), an initiative aimed at boosting translational research in the biomedical field in Cantabria. Among the awardees is Juan Marta Enguita, a neurologist specializing […]
Researcher at the Marqués de Valdecilla Research Institute (IDIVAL) and Professor at the University of Cantabria (UC), Mónica López Fanarraga, will deliver the lecture Nanorobots for the Medicine of the Future on Wednesday, August 20, at the Casa de Cultura Doctor Velasco in Laredo, as part of the UC Summer Courses. The talk, which is […]
The research, awarded and presented at international scientific forums, paves the way for new strategies in early detection and prevention of the disease. A study led by the Cognitive Impairment Unit at Marqués de Valdecilla University Hospital (HUMV) and the Marqués de Valdecilla Research Institute (IDIVAL) has shown that glial cells—microglia and astrocytes—display activation signs […]
The Clinical and Translational Research Group in Digestive Diseases at the Marqués de Valdecilla Research Institute (IDIVAL) has published an article on an innovative that could improve the safety of endoscopic treatment for early digestive neoplasms. This technique, called Cold Endoscopic Submucosal Dissection (Cold-ESD), is a new way to perform endoscopic resections — that is, removals […]
A study led from Cantabria analyzes how JAK-STAT pathway inhibitors affect the immune system The Immunopathology Research Group at the Marqués de Valdecilla Research Institute (IDIVAL), which includes professionals from the Marqués de Valdecilla, Laredo, and Sierrallana hospitals, has published a study that sheds new light on how a recently introduced treatment for rheumatoid arthritis […]
Researchers in Cantabria develop a simple, cost-effective test to help diagnose patients with low alkaline phosphatase levels Researchers from the Marqués de Valdecilla Research Institute (IDIVAL) and the Rare Diseases Unit at the Marqués de Valdecilla University Hospital (HUMV) have developed a new diagnostic method capable of identifying carriers of mutations in the ALPL gene, […]
The Marqués de Valdecilla Health Research Institute Foundation (IDIVAL) joined the European Human Resources Strategy for Researchers (HRS4R) in 2016 and obtained the “HR Excellence in Research” award in October 2018. This quality recognition is a key criterion for the renewal of accreditation as a Health Research Institute by the Carlos III Health Institute (ISCIII), […]
